ERBB2 and neoplasm: As previously discussed, we recently reported a quantitative tumor classification scheme based on patterns of pathway-associated signatures that can better match the complexity of the tumor, and in doing so, identified two subgroups characterized by high levels of HER2 pathway activity [14].